Empathogens

New York-based biotech Terran Biosciences has signed an agreement with French pharmaceutical company Pierre Fabre Médicament for worldwide exclusive rights to develop and commercialize a list of the latter's assets targeting neuropsychiatric conditions. The licensing deal includes...

Terran Biosciences, the NY-based biotech platform that develops transformational therapeutics announced the publication of four international PCT patent applications covering novel compounds and potentially improved versions of the empathogens methylone (also called bk-MDMA or MDMC...